Granules India Ltd.
NSE: GRANULES | BSE: 532482
₹859.55
₹-4.00
(-0.46%)
As on 08-Jul-2026IST
Market cap
₹21,259 Cr
Revenue (TTM)
₹5,366 Cr
P/E Ratio
35.7
P/B Ratio
4.2
Div. Yield
0.2 %
Quality Score
7/10
Growth Score
7/10
Valuation Score
3/10
Momentum Score
9/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹595 Cr
-
ROE
14.5 %
-
ROCE
16.2 %
-
Industry P/E
46.08
-
EV/EBITDA
18
-
Debt to Equity
0.1
-
Book Value
₹205.2
-
EPS
₹24.7
-
Face value
1
-
Shares outstanding
247,796,921
10 Years Aggregate
CFO
₹3,886.71 Cr
EBITDA
₹6,053.88 Cr
Net Profit
₹3,379.45 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Granules India
| 43.6 | 8.8 | 34.6 | 74.3 | 40.2 | 20.2 | 19.6 |
|
BSE Healthcare
| 13.3 | 4.9 | 18.1 | 9.6 | 23.8 | 13.6 | 11.9 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Granules India
| 0.2 | 43.8 | 27.2 | -5.2 | -6.4 | 188.9 | 35.6 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Granules India
|
859.6 | 21,258.5 | 5,365.6 | 595.0 | 16.6 | 13.3 | 35.7 | 4.2 |
| 3,454.5 | 28,300.8 | 1,339.4 | 356.4 | 33.2 | 23.2 | 79.4 | 17.1 | |
| 811.3 | 15,943.2 | 7,344.9 | 670.6 | 10.9 | 13.7 | 23.6 | 2.8 | |
| 430.8 | 16,500.1 | 2,268.6 | 150.1 | 10.6 | 5.4 | 92.1 | 4.2 | |
| 970.8 | 15,464.6 | 8,279.6 | 397.8 | 9.9 | 6.4 | 38.8 | 2.2 | |
| 966.3 | 17,332.5 | 4,078.3 | 1,371.9 | 30.2 | 15.9 | 12.2 | 1.9 | |
| 1,612.0 | 18,467.2 | 1,421.6 | -73.8 | 1.8 | -1.1 | -- | 3.2 | |
| 168.1 | 22,380.0 | 8,869.1 | -325.9 | 1.0 | -4 | -- | 2.8 | |
| 411.6 | 16,514.1 | 3,738.7 | 316.7 | 12.5 | 6.7 | 52.1 | 3.5 | |
| 1,824.5 | 29,655.6 | 3,373.0 | 199.0 | 12.6 | 5.9 | 139.2 | 6.0 |
Shareholding Pattern
View DetailsNews & Analysis
All News
Stock Rating update, March 15, 2024
2 min read•By Value Research
Why is this paracetamol maker bleeding?
4 min read•By Hemkesh Khattar
Companies falling short of cash
2 min read•By Rajan Gulati
1 min read•By Research Desk
1 min read•By Research Desk
6 min read•By Value Research
About Granules India
Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India, North America, Europe, Latin America, Africa, the Middle East, and internationally.... The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers various FDs, such as tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; and other products for oncology. The Company also exports its products. Granules India Limited was founded in 1984 and is based in Hyderabad, India. Read more
-
Incorporated
1991
-
Chairman
Krishna Prasad Chigurupati
-
Managing Director
Krishna Prasad Chigurupati
-
Headquarters
Hyderabad, Telangana
-
Website
Looking for more details about Granules India Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsNo News & Announcements are available.
FAQs for Granules India
What is the current share price of Granules India Ltd Today?
The share price of Granules India Ltd is ₹859.55 (NSE) and ₹857.90 (BSE) as of 08-Jul-2026 IST. Granules India Ltd has given a return of 40.2% in the last 3 years.
What is the current PB & PE ratio of Granules India Ltd?
The P/E ratio of Granules India Ltd is 35.73 times as on 08-Jul-2026, a 22 discount to its peers’ median range of 46.08 times.
The P/B ratio of Granules India Ltd is 4.18 times as on 08-Jul-2026, a 1 discount to its peers’ median range of 4.22 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
23.56
|
3.19
|
|
2024
|
25.71
|
3.25
|
|
2023
|
13.62
|
2.50
|
|
2022
|
18.40
|
2.96
|
|
2021
|
13.67
|
3.49
|
What is the 52 Week High and Low of Granules India Ltd?
The 52-week high and low of Granules India Ltd are Rs 879.10 and Rs 432.60 as of 09-Jul-2026.
What is the market cap of Granules India Ltd?
Granules India Ltd has a market capitalisation of ₹ 21,259 Cr as on 08-Jul-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Granules India Ltd?
Before investing in Granules India Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.